Primary Record
Ulimorelin
- In stock
- 3,317 g
- Purity
- 99.4 %
- CAS
- 842131-33-3
Compound Identifiers & Properties
- CAS
- 842131-33-3
- PubChem CID
- 11526696
- SMILES
- C[C@@H]1CN[C@H](C(=O)N([C@@H](C(=O)N[C@@H](C(=O)NCCCC2=CC=CC=C2O1)CC3=CC=C(C=C3)F)C)C)C4CC4
- Canonical SMILES
- C[C@@H]1CN[C@@H](C2CC2)C(=O)N(C)[C@H](C)C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)NCCCc2ccccc2O1
Names & Synonyms
- Ulimorelin
- Ulimorelina
- Ulimoreline
- ulimorelinum
- TZP-101
- TZP 101
- LGI67MCW2S
- Ulimorelin [USAN:INN]
- UNII-LGI67MCW2S
- TZP-101 FREE BASE
- ULIMORELIN [MI]
- ULIMORELIN [INN]
- 842131-33-3
- RefChem:919576
- Ulimorelin (USAN/INN)
- ULIMORELIN [USAN]
- D0W9VW
- ULIMORELIN [WHO-DD]
- SCHEMBL804500
- DTXSID00233139
- GTPL3535
- orb1706493
- TZP101
- CHEMBL1923502
- CHEMBL1963249
- SCHEMBL29375598
- DTXCID50155630
- CHEBI:177725
- GLXC-15727
- BDBM50359256
- DB12128
- CID11526696
- CID 11526696
- CID:11526696
- DA-68468
- HY-14903
- SID:196409672
- CS-0003624
- NS00072571
- J2.766.059B
- D09981
- Ulimorelin, TZP-101, TZP 101, TZP101
- C528884
- Q21098959
- (3R,6S,9R,12R)-6-cyclopropyl-12-[(4-fluorophenyl)methyl]-3,8,9-trimethyl-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione
- (2R,5S,8R,11R)-5-cyclopropyl-11-(4-fluorobenzyl)-2,7,8-trimethyl-4,5,7,8,10,11,13,14,15,16-decahydro-2H-benzo[q][1]oxa[4,7,10,13]tetraazacyclooctadecine-6,9,12(3H)-trione
- D-Phenylalanine, (2S)-N-((2R)-2-(2-(3-aminopropyl)phenoxy)propyl)-2-cyclopropylglycyl-N-methyl-D-alanyl-4-fluoro-, (3->1)-lactam
- D-Phenylalanine, (2S)-N-[(2R)-2-[2-(3-aminopropyl)phenoxy]propyl]-2-cyclopropylglycyl-N-methyl-D-alanyl-4-fluoro-, (3 inverted exclamation marku1)-lactam
- (2R,5S,8R,11R)-5-CYCLOPROPYL-11-((4-FLUOROPHENYL)METHYL)-2,7,8-TRIMETHYL- 2,3,4,5,7,8,10,11,13,14,15,16-DODECAHYDRO-6H-1,4,7,10,13- BENZOXATETRAAZACYCLOOCTADECINE-6,9,12-TRIONE
- (2R,5S,8R,11R)-5-cyclopropyl-11-((4-fluorophenyl)methyl)-2,7,8-trimethyl-3,4,5,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-2H-1,4,7,10,13-benzoxatetrazacyclooctadecine-6,9,12-trione
- (2R,5S,8R,11R)-5-cyclopropyl-11-[(4-fluorophenyl)methyl]-2,7,8-trimethyl-3,4,5,6,7,8,9,10,11,12,13,14,15,16-tetradecahydro-2H-1,4,7,10,13-benzoxatetrazacyclooctadecine-6,9,12-trione
- (2R,5S,8R,11R)-5-Cyclopropyl-11-[(4-fluorophenyl)methyl]-2,7,8-trimethyl-4,5,7,8,10,11,13,14,15,16-decahydro-2H-1,4,7,10,13-benzoxatetraazacyclooctadecine-6,9,12(3H)-trione
- (3R,6S,9R,12R)-3,8,9-Trimethyl-6-cyclopropyl-12-(4-fluorobenzyl)-2-oxa-5,8,11,14-tetraazabicyclo[16.4.0]docosane-1(18),19,21-triene-7,10,13-trione
- (3R,6S,9R,12R)-6-cyclopropyl-12-((4-fluorophenyl)methyl)-3,8,9-trimethyl-2-oxa-5,8,11,14-tetrazabicyclo(16.4.0)docosa-1(22),18,20-triene-7,10,13-trione
- (3R,6S,9R,12R)-6-cyclopropyl-12-[(4-luorophenyl)methyl]-3,8,9-trimethyl-2-oxa-5,8,11,14-tetrazabicyclo[16.4.0]docosa-1(22),18,20-triene-7,10,13-trione
- 2H-1,4,7,10,13-BENZOXATETRAAZACYCLOOCTADECINE-6,9,12(3H)-TRIONE, 5-CYCLOPROPYL-11- ((4-FLUOROPHENYL)METHYL)-4,5,7,8,10,11,13,14,15,16-DECAHYDRO-2,7,8-TRIMETHYL-, (2R,5S,8R,11R)-
- D-Phenylalanine, (2S)-N-((2R)-2-(2-(3-aminopropyl)phenoxy)propyl)-2- cyclopropylglycyl-N-methyl-D-alanyl-4-fluoro-, (3-1)-lactam